BRIEF: Ascentage Pharma prices U.S. IPO at 20% discount, to raise up to $130 million
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) announced Friday that it will offer 7.325 million American Depositary Shares (ADS) in its upcoming U.S. listing at an issue price of $17.25…
BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Monday, a necessary step before it can make an overseas…
Ascentage Pharma soars on deal with cancer drug competitor
The Chinese drug developer put a rocket booster under its share price after enlisting a Japanese rival as a new equity partner and unveiling plans for a U.S. listing Key…
FAST NEWS: Ascentage’s manufacturing center gets EU stamp of approval
The latest: Ascentage Pharma Group International (6855.HK) announced on Tuesday it recently received a zero-deficiency report following a Good Manufacturing Practice (GMP) compliance audit of its global manufacturing center by…
FAST NEWS: Hutchmed, Zai Lab, Ascentage Drugs Land on China Reimbursement List
The latest: Products from Hutchmed (China) Ltd. (HCM.US; 0013.HK), Zai Lab Ltd. (ZLAB.US; 9688.HK) and Ascentage Pharma Group (6855.HK) were among 111 new drugs selected for new inclusion in the…
Amid Slowing Sales at Home, Innovent Biologics Stumbles Overseas
Cancer drug maker ended a tie-up to bring one of its drugs to North America last week, less than two months after its best-selling product was rejected by the FDA…
Recent Articles
RELATED ARTICLES
-
BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
6855.HK
-
BRIEF: Xtep to raise $130 million through share placement, convertible bond issue
1368.HK
-
BRIEF: MicroPort MedBot raises $35 million in share placement at 20% discount
2252.HK
-
BRIEF: Robosense raises HK$270 million in share placement at 8% discount
2498.HK
-
BRIEF: Guming to raise $220 million in Hong Kong IPO
1364.HK
-
BRIEF: SF Holding to raise $800 million through IPO backed by Oaktree, Xiaomi
6936.HK 002352.SHE
-
BRIEF: China Ruyi raises $500 million in share placement at slight discount
0136.HK
